Vaccination against yellow fever in rheumatic diseases

Yellow fever (YF) is an obligate, transmissible, feral herd infectious disease characterized by multiple organ dysfunction and high mortality rates. The intensification of international relations and tourist flows, including those to the YF endemic areas in recent years has substantially increased t...

Full description

Bibliographic Details
Main Authors: B. S. Belov, G. M. Tarasova, N. V. Muravyeva
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2019-10-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/966
id doaj-e3c28cccfd474ef59cec07102027750f
record_format Article
spelling doaj-e3c28cccfd474ef59cec07102027750f2021-07-29T09:00:13ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2019-10-011349910310.14412/1996-7012-2019-4-99-1032218Vaccination against yellow fever in rheumatic diseasesB. S. Belov0G. M. Tarasova1N. V. Muravyeva2V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyYellow fever (YF) is an obligate, transmissible, feral herd infectious disease characterized by multiple organ dysfunction and high mortality rates. The intensification of international relations and tourist flows, including those to the YF endemic areas in recent years has substantially increased the value of vaccination against this infection in patients on immunosuppressive therapy for immunological disorders, including rheumatic diseases (RDs). In this connection, the recently published guidelines by the experts of the Brazilian Society of Rheumatology on the efficiency and safety of immunization against YL in patients with chronic immune-mediated inflammatory diseases (including RDs) are of great interest. The main provisions of these guidelines are presented in this paper.https://mrj.ima-press.net/mrj/article/view/966yellow fevervaccinationrheumatic diseases
collection DOAJ
language Russian
format Article
sources DOAJ
author B. S. Belov
G. M. Tarasova
N. V. Muravyeva
spellingShingle B. S. Belov
G. M. Tarasova
N. V. Muravyeva
Vaccination against yellow fever in rheumatic diseases
Современная ревматология
yellow fever
vaccination
rheumatic diseases
author_facet B. S. Belov
G. M. Tarasova
N. V. Muravyeva
author_sort B. S. Belov
title Vaccination against yellow fever in rheumatic diseases
title_short Vaccination against yellow fever in rheumatic diseases
title_full Vaccination against yellow fever in rheumatic diseases
title_fullStr Vaccination against yellow fever in rheumatic diseases
title_full_unstemmed Vaccination against yellow fever in rheumatic diseases
title_sort vaccination against yellow fever in rheumatic diseases
publisher IMA-PRESS LLC
series Современная ревматология
issn 1996-7012
2310-158X
publishDate 2019-10-01
description Yellow fever (YF) is an obligate, transmissible, feral herd infectious disease characterized by multiple organ dysfunction and high mortality rates. The intensification of international relations and tourist flows, including those to the YF endemic areas in recent years has substantially increased the value of vaccination against this infection in patients on immunosuppressive therapy for immunological disorders, including rheumatic diseases (RDs). In this connection, the recently published guidelines by the experts of the Brazilian Society of Rheumatology on the efficiency and safety of immunization against YL in patients with chronic immune-mediated inflammatory diseases (including RDs) are of great interest. The main provisions of these guidelines are presented in this paper.
topic yellow fever
vaccination
rheumatic diseases
url https://mrj.ima-press.net/mrj/article/view/966
work_keys_str_mv AT bsbelov vaccinationagainstyellowfeverinrheumaticdiseases
AT gmtarasova vaccinationagainstyellowfeverinrheumaticdiseases
AT nvmuravyeva vaccinationagainstyellowfeverinrheumaticdiseases
_version_ 1721250215665598464